Valued at $106.3M at its later-stage round, Dec 2025. Nothing has traded since.
- ·The complete investor list: 15 names
- ·Watch Auron Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Auron Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2024 | Early Stage VC | $27.3M | ▮ | ▮ |
| Jul 2022 | Early Stage VC | $38.4M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $15.4M | ▮ | ▮ |
| Jun 2018 | Debt | $660K | ▮ | ▮ |
Membership and data by Private Market View
Auron Therapeutics valuation
Auron Therapeutics was valued at $106 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Auron Therapeutics raised?
Auron Therapeutics has raised $90.7 million across 4 recorded rounds since 2018. The largest was a $660,000 debt round in Jun 2018; the most recent was a $27.3 million early-stage round in Dec 2024.
Auron Therapeutics has filed 5 Form Ds with the SEC since 2018, most recently in Dec 2024 ($13.4 million sold to 15 investors).
How Auron Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Auron Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Auron Therapeutics
- What is Auron Therapeutics worth?
- Auron Therapeutics is valued at $106.3M as of Oct 2026. Valued at $106.3M at its later-stage round, Dec 2025. Nothing has traded since.
- How much has Auron Therapeutics raised?
- Auron Therapeutics has raised $90.7M in total funding across 4 recorded rounds.
- When did Auron Therapeutics last raise?
- Auron Therapeutics last raised in Dec 2024 (Early Stage VC), raising $27.3M.